Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.875 USD | -1.83% | 0.00% | -28.79% |
Apr. 08 | Transcript : Cue Biopharma, Inc., Q4 2023 Earnings Call, Apr 08, 2024 | |
Apr. 08 | North American Morning Briefing : Inflation Data, -2- | DJ |
Financials (USD)
Sales 2024 * | 9.01M | Sales 2025 * | 15.73M | Capitalization | 92.91M |
---|---|---|---|---|---|
Net income 2024 * | -57M | Net income 2025 * | -68M | EV / Sales 2024 * | 10.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.91 x |
P/E ratio 2024 * |
-1.85
x | P/E ratio 2025 * |
-1.9
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.03% |
Latest transcript on Cue Biopharma, Inc.
1 day | -12.39% | ||
1 week | +0.26% | ||
Current month | +0.53% | ||
1 month | -6.37% | ||
3 months | -18.72% | ||
6 months | -18.38% | ||
Current year | -27.65% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Passeri
CEO | Chief Executive Officer | 63 | 16-07-31 |
Anish Suri
PSD | President | 50 | 18-06-30 |
Kerri-Ann Millar
DFI | Director of Finance/CFO | 54 | 17-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-06-25 |
Daniel Passeri
CEO | Chief Executive Officer | 63 | 16-07-31 |
Peter Kiener
BRD | Director/Board Member | 72 | 16-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% | ||
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 1.88 | -1.57% | 102 296 |
24-05-08 | 1.91 | -12.39% | 261,073 |
24-05-07 | 2.18 | +4.81% | 240,273 |
24-05-06 | 2.08 | -2.35% | 319,295 |
24-05-03 | 2.13 | +13.30% | 663,094 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.65% | 92.91M | |
+2.93% | 108B | |
+0.67% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- CUE Stock